10 Turning Points in Pharmaceutical Packaging

Forcinio,Hallie;

10 Turning Points in Pharmaceutical Packaging

July 1, 2001

By Hallie Forcinio

News

Article

Pharmaceutical TechnologyPharmaceutical Technology-07-02-2001

Volume 25

Issue 7

In the past three decades, several industry-altering episodes have changed the face of pharmaceutical packaging.

External Link - article-22860.pdf

Articles in this issue

Musings on the Past 25 Years

Reflections on Changes at FDA

Deliver the Dose

Middle-European Pharmaceutics in a Changing World

The BCS: Where Do We Go From Here?

The Role of USP in the Assessment of Microbiological Quality of Pharmaceuticals

From Inactive Ingredients to Pharmaceutical Excipients

Am I Going Backwards?

The Filter Scene: Old and New

Catching Up with Expert Systems

25 Years of Change in the Parenteral Technology Field

The Future State of Computer Validation, Part I

Statistical Thinking

2001: An Odyssey in Inhaler Formulation and Design

What Is the "Correct" Method to Use for Particle-Size Determination?

Related Content

mainz,Rhineland-Palatinate /germany - 16 07 2022: the biontech company building and flags in mainz germany | Image Credit: © Tobias Arhelger - stock.adobe.com

CureVac to Be Acquired by BioNTech in $1.25B Deal to Advance mRNA Cancer Therapies

Christopher Cole

June 12th 2025

Article

The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer immunotherapies.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

June 25th 2024

Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

MilliporeSigma and Simtra Launch Five-Year Agreement for Drug Substance, Drug Manufacturing Services

Patrick Lavery

June 11th 2025

Article

The agreement has been designed to offer a turnkey service to companies seeking faster time to market.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

April 30th 2024

Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

China’s NMPA Approves Merck KGaA Treatment for Tenosynovial Giant Cell Tumor

Patrick Lavery

June 10th 2025

Article

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with TGCTs that require systemic treatment.